RxDoctor Payments DataLook up a doctor →

INCRELEX: payments to doctors

Payments that named INCRELEX as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$145K
Providers
477
Transactions
839
Average per transaction
$172

The per-transaction average — $172 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 477 providers the average total is $303, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Eton Pharmaceuticals, Inc.$93,91164.9%
Ipsen Biopharmaceuticals, Inc$49,63634.3%
Ipsen Biopharm Limited$1,1550.8%
← All drugs & devices